Molecular Organization of C9 Within the Membrane Attack Complex of Complement. Induction of Circular C9 Polymerization by the C5b-8 Assembly

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1982 Jul 1

PMID 6177822

Citations 53

Authors

E R Podack

J Tschoop

H J MULLER-EBERHARD

Affiliations

Soon will be listed here.

Abstract

Evidence has been presented suggesting that during assembly of the membrane attack complex (MAC) of complement, the C5b-8 complex induces polymerization of C9. The C9 polymer was detected by sodium dodecyl sulfate (SDS) gel electrophoresis of MAC isolated from complement-lysed erythrocytes. It resembled the previously described polymerized C9 (poly C9) produced from isolated monomeric C9 by prolonged incubation at 37 degrees C in that it was resistant to dissociation by SDS and reducing agents and had an apparent molecular weight of approximately 1.1 million. The presence of poly C9 in the MAC was further supported by the expression of identical neoantigens by the MAC and poly C9 and by the high C9 content of the MAC relative to its other constituents. Isolated C8 in solution was found to have a single C9-binding site. In mixture, the two proteins formed a reversible equimolar complex that had a sedimentation coefficient of 10.5S. In contrast, a single, cell-bound C5b-8 complex was found to bind up to 12-15 C9 molecules and clusters of C5b- 8 bound 6-8 C9 molecules per C8 molecule. In either case, typical ultrastructural membrane lesions were observed, suggesting that the membrane lesion is identical with the tubular poly C9 consisting of 12-16 C9 molecules, and that the MAC can have either the composition (C5b-8)polyC9 or (CSb-8)(2)polyC9. When C9 input was restricted so that the molar C9/C8 ratio was less than or equal to 3, C9-induced aggregates of C5b-8 were observed but virtually no circular membrane lesions were found. We suggest, therefore, that C9, at low dosage, causes cross-linking of multiple C5b-8 complexes within the target membrane and that, at high dosage, C9 is polymerized by C5b-8 to form a transmembrane channel within the MAC assembly. It is primarily the C9 polymer that evokes the ultrastructural image of the MAC or of membrane lesions caused by complement.

Citing Articles

The Interactions of the Complement System with Human Cytomegalovirus.

Lujan E, Zhang I, Garon A, Liu F Viruses. 2024; 16(7).

PMID: 39066333 PMC: 11281448. DOI: 10.3390/v16071171.

The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.

Avdonin P, Blinova M, Generalova G, Emirova K, Avdonin P Biomolecules. 2024; 14(1).

PMID: 38254639 PMC: 10813406. DOI: 10.3390/biom14010039.

Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?.

Spasiano A, Palazzetti D, Dimartino L, Bruno F, Baccaro R, Pesce F Int J Mol Sci. 2023; 24(19).

PMID: 37833944 PMC: 10572301. DOI: 10.3390/ijms241914496.

Subversion of the Complement System by Pseudomonas aeruginosa.

Hastings C, Syed S, Marques C J Bacteriol. 2023; 205(8):e0001823.

PMID: 37436150 PMC: 10464199. DOI: 10.1128/jb.00018-23.

OMPdb: A Global Hub of Beta-Barrel Outer Membrane Proteins.

Roumia A, Tsirigos K, Theodoropoulou M, Tamposis I, Hamodrakas S, Bagos P Front Bioinform. 2022; 1:646581.

PMID: 36303794 PMC: 9581022. DOI: 10.3389/fbinf.2021.646581.

References

Stolfi R . Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system. J Immunol. 1968; 100(1):46-54. View

HADDING U, MULLER-EBERHARD H . The ninth component of human complement: isolation, description and mode of action. Immunology. 1969; 16(6):719-35. PMC: 1409673. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

KOLB W, Haxby J, Arroyave C, MULLER-EBERHARD H . Molecular analysis of the membrane attack mechanism of complement. J Exp Med. 1972; 135(3):549-66. PMC: 2139138. DOI: 10.1084/jem.135.3.549. View

Mayer M . Mechanism of cytolysis by complement. Proc Natl Acad Sci U S A. 1972; 69(10):2954-8. PMC: 389682. DOI: 10.1073/pnas.69.10.2954. View

ROMMEL F, Mayer M . Studies of guinea pig complement component C9: reaction kinetics and evidence that lysis of EAC1-8 results from a single membrane lesion caused by one molecule of C9. J Immunol. 1973; 110(3):637-47. View

KOLB W, MULLER-EBERHARD H . Mode of action of human C9: adsorption of multiple C9 molecules to cell-bound C8. J Immunol. 1974; 113(2):479-88. View

KOLB W, MULLER-EBERHARD H . The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex. J Exp Med. 1975; 141(4):724-35. PMC: 2189744. View

Bhakdi S, Ey P . Isolation of the terminal complement complex from target sheep erythrocyte membranes. Biochim Biophys Acta. 1976; 419(3):445-57. DOI: 10.1016/0005-2736(76)90258-3. View

10.

Petersen B, Graham J, Brooks G . Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity. J Clin Invest. 1976; 57(2):283-90. PMC: 436652. DOI: 10.1172/JCI108279. View

11.

Klob W, MULLER-EBERHARD H . The membrane attack mechanism of complement: the three polypeptide chain structure of the eigth component (C8). J Exp Med. 1976; 143(5):1131-9. PMC: 2190193. DOI: 10.1084/jem.143.5.1131. View

12.

Tranum-Jensen J, Bhakdi S, Bjerrum O, Speth V . Complement lysis: the ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes. Scand J Immunol. 1978; 7(1):45-6. DOI: 10.1111/j.1365-3083.1978.tb00425.x. View

13.

Fraker P, SPECK Jr J . Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978; 80(4):849-57. DOI: 10.1016/0006-291x(78)91322-0. View

14.

Podack E, Biesecker G, KOLB W, MULLER-EBERHARD H . The C5b-6 complex: reaction with C7, C8, C9. J Immunol. 1978; 121(2):484-90. View

15.

Podack E, MULLER-EBERHARD H . Binding of desoxycholate, phosphatidylcholine vesicles, lipoprotein and of the S-protein to complexes of terminal complement components. J Immunol. 1978; 121(3):1025-30. View

16.

Bhakdi S, Tranum-Jensen J . Molecular nature of the complement lesion. Proc Natl Acad Sci U S A. 1978; 75(11):5655-9. PMC: 393026. DOI: 10.1073/pnas.75.11.5655. View

17.

Biesecker G, Podack E, Halverson C, MULLER-EBERHARD H . C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent membrane lesions. J Exp Med. 1979; 149(2):448-58. PMC: 2184804. DOI: 10.1084/jem.149.2.448. View

18.

Podack E, Biesecker G, MULLER-EBERHARD H . Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins. Proc Natl Acad Sci U S A. 1979; 76(2):897-901. PMC: 383086. DOI: 10.1073/pnas.76.2.897. View

19.

Schreiber R, Morrison D, Podack E, MULLER-EBERHARD H . Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins. J Exp Med. 1979; 149(4):870-82. PMC: 2184846. DOI: 10.1084/jem.149.4.870. View

20.

Esser A, KOLB W, Podack E, MULLER-EBERHARD H . Molecular reorganization of lipid bilayers by complement: a possible mechanism for membranolysis. Proc Natl Acad Sci U S A. 1979; 76(3):1410-4. PMC: 383261. DOI: 10.1073/pnas.76.3.1410. View